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Abstract  30 
Staphylococcus aureus skin infection is a frequent and recurrent problem in children with the 31 
common inflammatory skin disease atopic dermatitis (AD).  S. aureus colonises the skin of 32 
the majority of children with AD and exacerbates the disease.  The first step during 33 
colonisation and infection is bacterial adhesion to the cornified envelope of corneocytes in 34 
the outer layer stratum corneum.  Corneocytes from AD skin are structurally different to 35 
corneocytes from normal healthy skin.  The objective of this study was to identify bacterial 36 
proteins that promote the adherence of S. aureus to AD corneocytes.  S. aureus strains from 37 
clonal complex 1 and 8 were more frequently isolated from infected AD skin than from the 38 
nasal cavity of healthy children.  AD strains had increased ClfB ligand binding activity 39 
compared to normal nasal carriage strains.  Adherence of single S. aureus bacteria to 40 
corneocytes from AD patients ex vivo was studied using atomic force microscopy.  Bacteria 41 
expressing ClfB recognised ligands distributed over the entire corneocyte surface.  The 42 
ability of an isogenic ClfB-deficient mutant to adhere to AD corneocytes was greatly reduced 43 
compared to its parent clonal complex 1 clinical strain.  ClfB from clonal complex 1 strains 44 
had a slightly higher binding affinity for its ligand compared to ClfB from other clonal 45 
complexes.  Our results provide new insights into the first step in the establishment of S. 46 
aureus colonisation in AD patients.  ClfB is a key adhesion molecule for the interaction of 47 
S.aureus with AD corneocytes and represents a target for intervention.  48 
  49 
 50 
 51 
 52 
 53 
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Introduction   54 
The skin of the majority of individuals with the inflammatory skin disease atopic dermatitis 55 
(AD) is heavily colonised by Staphylococcus aureus (1).  The healthy population has a much 56 
lower rate of persistent carriage (~ 20%) and colonisation is usually confined to the nasal 57 
cavity (2).  S. aureus colonization of skin appears to post-date the development of AD, at 58 
least in infant populations (3).  In established AD the density of S. aureus on lesional and 59 
non-lesional skin has a strong relationship to disease severity (4). A major risk factor for the 60 
development of AD is loss-of-function mutations in the filaggrin (FLG) gene (5, 6) which 61 
lead to a reduced level of natural moisturising factor (NMF) in the stratum corneum 62 
accompanied by a skin epidermal barrier defect and an elevated pH (7).  When the skin 63 
barrier is compromised, factors produced by S. aureus exacerbate the symptoms of AD (8).  64 
Several S. aureus factors have been linked to increased inflammation and disease severity in 65 
AD including α-toxin (9), the staphylococcal superantigens (10) and δ-toxin (11). 66 
S. aureus adheres to the cornified envelope of corneocytes in the stratum corneum.  67 
Corneocytes from AD skin have an altered surface topology compared to corneocytes from 68 
normal healthy skin, physical characteristics that are largely determined by levels of 69 
expressed filaggrin and NMF (12).  The factors promoting colonisation of atopic skin have 70 
not yet been identified.  Several S. aureus proteins are known to bind to host molecules, some 71 
of which may be present on the surface of the stratum corneum of AD skin.  For example, 72 
compared with healthy skin, higher levels of fibronectin are found in the stratum corneum of 73 
patients with AD and the expression of the S. aureus cell wall anchored (CWA) fibronectin 74 
binding proteins (FnBPs) A and B enhances bacterial adherence to AD skin biopsy sections 75 
(13). The CWA protein clumping factor B (ClfB) binds to the cornified envelope proteins 76 
loricrin and cytokeratin 10 in the moist squamous epithelium promoting colonization of the 77 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
5 
 
anterior nares (14, 15).  ClfB and FnBPs are expressed at higher levels by bacteria grown in 78 
vitro at the pH of AD skin than by bacteria grown at the low pH typical of healthy skin (16).  79 
The binding of ClfB to its ligands is well understood at the molecular level. The X-ray crystal 80 
structure of the ligand-binding region of ClfB has been solved both in the apo form and with 81 
a peptide ligand bound (17).  Binding occurs by the ‘dock, lock and latch’ mechanism 82 
whereby a short peptide from loricrin or cytokeratin 10 binds to a hydrophobic trench located 83 
between the separately folded N2 and N3 subdomains (18).  A conformational change at the 84 
C-terminus of N3 locks the ligand in place. 85 
The aim of our study was to identify the bacterial factors that promote adherence of S. 86 
aureus to corneocytes from AD skin.  We studied clinically relevant strains of S. aureus from 87 
the infected lesional skin of children with AD.  Molecular typing methods revealed the 88 
population structure of strains of S. aureus from AD skin infection  and in vitro experiments 89 
demonstrated that AD strains adhere more strongly to a ClfB ligand (the loricrin-derived 90 
peptide L2v) than control strains of S. aureus isolated from the nares of a healthy cohort of 91 
children with no history of AD.  Isogenic clfB knockout mutants were generated in AD 92 
strains representing the most common lineages of S. aureus isolated from paediatric patients.  93 
The ability of an AD strain and its isogenic ClfB-deficient mutant to adhere to corneocytes 94 
from patients with AD was studied ex vivo and using atomic force microscopy (19).   95 
  96 
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Materials and Methods 97 
Patient populations 98 
The AD patients enrolled in this study were presenting for the first time at a tertiary referral 99 
centre at Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland between September 2012 100 
and September 2014.  An experienced paediatric dermatologist (MAMcA ADI, or both) made 101 
the diagnosis and recorded the disease phenotype.  All patients met the United Kingdom 102 
diagnostic criteria for AD (20) and had moderate or severe disease. Exclusion criteria from 103 
the study included patients who had pyrexial illness in the preceding 2 weeks and those who 104 
had received immunosuppressive systemic therapy, such as oral corticosteroids, in the 105 
preceding 3 months. The study was conducted in accordance with the Helsinki Declarations 106 
and was approved by the Research Ethics Committee of Our Lady's Children's Hospital, 107 
Dublin, Ireland. Full written informed consent was obtained from all patients' parents. The 108 
children were treatment naive (for topical steroids, antibiotics or antimicrobials) at 109 
presentation. Patient demographics and disease characteristics are summarized in Table S1. 110 
Age-matched control subjects were children attending the Emergency Department of Temple 111 
Street Children’s University Hospital, Dublin, Ireland between July and August 2009. 112 
Subjects were requested to complete a questionnaire and those whose reason for presentation 113 
was not of an infective origin (i.e. trauma, accompanying sibling, etc.) and who had no 114 
history of skin diseases (including AD), allergic rhinitis or bronchial asthma were selected for 115 
inclusion in the study. Ethical permission was received from the Temple Street Children’s 116 
University Hospital Ethics Committee and full written informed consent was obtained from 117 
all patients' parents. The mean age at recruitment was 30.48 months, and 53.06% of the 118 
subjects were female. 119 
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 120 
FLG genotyping 121 
All AD patients were screened for the 9 most common FLG mutations found in the Irish 122 
population (R501X, Y2092X, 2282del4, R2447X, S3247X, R3419X, 3702delG, S1040X, 123 
and G1139X) from DNA extracted from a blood sample. The methods used have been 124 
previously described (21). 125 
 126 
Collection of strains and molecular typing of S. aureus 127 
To collect AD strains, swabs were taken from a clinically infected site on the patient’s skin 128 
(Table S1) and streaked onto mannitol salt agar to select for S. aureus.  S. aureus strains from 129 
a healthy cohort (children with no history of AD and asymptomatic nasal carriage) were 130 
recovered by rotational swabbing of the anterior nares of one nostril. In total 44 AD strains 131 
and 49 nasal carriage isolates were studied.  Strains were single colony purified on sheep 132 
blood agar and a single colony isolated from each patient was spa typed.  The spa types were 133 
classified using two online nomenclature systems (Ridom and eGenomics) (22).  One or more 134 
isolates of each unique spa type were subjected to multilocus sequence typing (MLST), and 135 
clonal complex (CC) was assigned by eBURST analysis of the MLST data.  136 
 137 
Bacterial growth conditions and strain construction 138 
S. aureus was grown in Tryptic Soy Broth (TSB) at 37°C.  SH1000 is a commonly used 139 
laboratory strain of S. aureus (23).  Plasmid DNA isolated from E. coli strain SA08B (24) 140 
was used to transform CC1 strains of S. aureus using standard procedures (25).  Deletion of 141 
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the clfB gene was achieved by allelic exchange as described previously (14).  The mutation 142 
was confirmed by DNA sequencing of a PCR amplimer. The clfB mutant was phenotypically 143 
indistinguishable from the parent strain in terms of growth rate and haemolysis on sheep 144 
blood agar (data not shown).  Plasmids pCU1 (26) and pCU1::clfB (27) were transformed 145 
into AD08CC1∆clfB. 146 
 147 
Extraction of cell wall proteins and western immunoblotting 148 
Bacteria from an overnight culture were washed in TSB, diluted 1:200 and allowed to grow 149 
to an OD600 = 0.3 - 0.5 in TSB.  Bacteria were washed in phosphate-buffered saline (PBS) 150 
and resuspended to an OD600 of 10 in lysis buffer (50 mM Tris/HCl, 20 mM MgCl2, pH 7.5) 151 
supplemented with raffinose (30% w/v, Sigma) and complete protease inhibitors (40 μl/ml, 152 
Roche).  Cell wall proteins were solubilised by incubation with lysostaphin (100 μg/ml; 153 
AMBI, New York) for 8 min at 37°C.  Protoplasts were removed by centrifugation at 154 
16,000 × g for 5 min and the supernatant containing solubilised cell wall proteins was 155 
aspirated and boiled for 10 min in final sample buffer.  Proteins were separated by sodium 156 
dodecyl sulfate polyacrylamide gel electrophoresis on 7.5% (w/v) polyacrylamide gels, 157 
transferred onto polyvinylidene difluoride (Roche) and blocked in 10% (w/v) skimmed milk 158 
proteins.  Blots were probed with polyclonal rabbit antibodies against the ClfB A domain 159 
(1:1000) and bound antibody was detected using horseradish peroxidise-conjugated protein A 160 
(1:500, Sigma).  Reactive bands were visualised using the LumiGLO reagent and peroxide 161 
detection system (Cell Signalling Technology) using the ImageQuant Las 4000 imaging 162 
system and ImageQuant TL software (GE Healthcare).   163 
 164 
Bacterial adherence to L2v 165 
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Recombinant GST-tagged L2v was purified from E. coli as previously described (14) using a 166 
GSTrap FF purification column (GE Healthcare) according to the manufacturer's instructions 167 
and diluted in coating buffer (0.1 M NaHCO3, 33 mM Na2CO3, pH 9.6).  Wells of a microtitre 168 
plate (Nunc maxisorb) were incubated with a solution of L2v (0.625 µg/ml) overnight at 4°C. 169 
Wells were blocked with bovine serum albumin (BSA, 5% (w/v)) for 2 h at 37°C.  S. aureus 170 
was grown to an OD600 = 0.3 - 0.5 in TSB.  Washed bacteria were adjusted to an OD600 of 1.0 171 
in PBS, and 100 µl was added to each well and incubated for 1.5 h at 37 °C. Wells were 172 
washed with PBS, and adherent cells fixed with formaldehyde (25% v/v), stained with crystal 173 
violet and the A570 nm measured. Each experiment was performed three times. 174 
Sampling of the stratum corneum by tape stripping and transepidermal water loss 175 
measurement 176 
A clinically unaffected site on the patient's volar forearm was used for transepidermal water 177 
loss (TEWL) measurements and stratum corneum sampling using a previously described 178 
method (28).  TEWL was determined by using a Tewameter 300 (Courage and Khazaka 179 
Electronic GmbH, Cologne, Germany).  To sample the stratum corneum, circular adhesive 180 
tape strips (3.8 cm2, D-Squame; Monaderm, Monaco, France) were attached to volar forearm 181 
skin and pressed for 10 seconds with a constant pressure (225 g/cm2) by using a D-Squame 182 
Pressure Instrument D500 (CuDerm, Dallas, Tex). The tape strip was then gently removed 183 
and placed in a closed vial. Eight consecutive tape strips were sampled, all from the same 184 
site.  The tape strips were immediately stored at −80°C until analysis.  The fifth strip was 185 
used for NMF measurements and the eighth strip for AFM. 186 
 187 
Natural moisturising factor measurement 188 
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Natural moisturising factor analysis was performed on the fifth consecutive strip, according 189 
to methods described in detail previously (29).  Briefly, the tape strip was extracted with 25% 190 
(wt/wt) ammonia solution.  After evaporation of the ammonia extract, the residue was 191 
dissolved in 250 μl of pure water and analyzed by using high performance liquid 192 
chromatography. The NMF concentration was normalized for the protein amount determined 193 
with a Pierce Micro BCA protein assay kit (Thermo Fischer Scientific, Rockford, Ill; referred 194 
to as the Pierce assay) to compensate for a variable amount of the stratum corneum on the 195 
tape. 196 
 197 
Atomic Force Microscopy 198 
Corneocyte imaging.  Atomic force microscopy imaging was performed on the eighth tape 199 
strip in contact mode at a resolution of 512 lines, using SiNO3 cantilevers (MSCT, Bruker, 200 
nominal spring constant of 0.01 N/m), in Tris buffered saline (TBS, Tris 50 mM, NaCl 150 201 
mM, pH = 7.4) at room temperature.  For each condition, at least 3 different corneocytes were 202 
imaged.  203 
 204 
Multiparametric imaging. Multiparametric images of corneocytes were recorded in TBS 205 
using the Quantitative ImagingTM mode available on the Nanowizard III AFM (JPK 206 
Instruments, Germany). Images were obtained using a S. aureus AD08CC1 or AD08CC1∆clfB 207 
cell probe (see below for cell probe preparation) at 128 pixels x 128 pixels, with an applied 208 
force kept at 1.0 nN, and a constant approach/retract speed of 40.0 µm/s (z-range of 1 µm). 209 
The cantilevers spring constants were determined by the thermal noise method. For each 210 
condition, experiments were repeated for at least 3 different cell pairs. 211 
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Single-cell force spectroscopy. To prepare bacterial cell probes, colloidal probes were 212 
obtained by attaching a single silica microsphere (6.1 µm diameter, Bangs Laboratories) with 213 
a thin layer of UV-curable glue (NOA 63, Norland Edmund Optics) on triangular tipless 214 
cantilevers (NP-O10, Bruker) and using a Nanowizard III AFM (JPK Instrument, Berlin, 215 
Germany). Cantilevers were then immersed for 1 h in TBS (pH = 8.5) containing dopamine 216 
hydrochloride (4 mg/ml, Sigma-Aldrich), rinsed in TBS, and used directly for cell probe 217 
preparation.  The nominal spring constant of the colloidal probe cantilever was determined by 218 
the thermal noise method. Then, 50 µl of a diluted cell suspension was deposited into the 219 
petri dish containing corneocytes, at a distinct location within the petri dish; 3 ml of PBS was 220 
added to the system. The colloidal probe was brought into contact with an isolated bacterium 221 
and retracted to attach the bacterial cell; proper attachment of the cell on the colloidal probe 222 
was checked using optical microscopy.  Cell probes were used to measure cell-cell interaction 223 
forces at room temperature, using an applied force of 0.25 nN, a constant approach-retraction 224 
speed of 1.0 µm/s and a contact time of 100 ms. Data were analyzed using the Data 225 
Processing software from JPK Instruments (Berlin, Germany). Adhesion forces values were 226 
obtained by calculating the maximum adhesion force for each force curve recorded on 227 
corneocytes and the data for five different cell pairs in each condition were pooled. 228 
Recombinant ClfB protein expression and purification. DNA encoding the N2N3 229 
subdomains of ClfB (residues 201-542) was amplified by PCR using genomic DNA from S. 230 
aureus strain AD08CC1 or AD22CC30 as template and cloned into the vector pQE30.  E. coli 231 
TOPP3 carrying the recombinant plasmids was grown to late exponential phase (OD600 = 0.6) 232 
and induced with IPTG.  CC1 and CC30 ClfB harbouring an N-terminal hexahistidine tag 233 
were purified using Ni2+ affinity chromatography. 234 
Surface plasmon resonance.  Surface plasmon resonance (SPR) was performed using the 235 
BIAcore X100 system (GE Healthcare). Goat anti-GST IgG (30 μg/ml, GE Healthcare) was 236 
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diluted in 10 mM sodium acetate buffer at pH 5.0 and immobilized on CM5 sensor chips 237 
using amine coupling. This was performed using 1-ethyl-3-(3-dimethylaminopropyl) 238 
carbodiimide hydrochloride, followed by N-hydroxysuccinimide and ethanolamine 239 
hydrochloride, as described by the manufacturer. Recombinant GST-tagged L2v (10–30 240 
µg/ml) in PBS was passed over the anti-GST surface of one flow cell while recombinant GST 241 
(10–30 µg/ml) was passed over the other flow cell to provide a reference surface. Increasing 242 
concentrations of rClfB N2N3 in PBS were passed in over the surface of the chip without 243 
regeneration. All sensorgram data were subtracted from the corresponding data from the 244 
reference flow cell. The response generated from injection of buffer over the chip was also 245 
subtracted from each sensorgram. Data was analysed using the BIAevaluation software 246 
version 3.0. A plot of the level of binding (response units) at equilibrium against 247 
concentration of rClfB N2N3 was used to determine the KD. The data shown is representative 248 
of 3 individual experiments. 249 
Statistical Tests 250 
Statistical significance was determined with the Student's t-test, using GRAPHPAD software. 251 
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Results 252 
Population structure of atopic dermatitis strains of S. aureus. 253 
The skin of AD patients is frequently colonised by S. aureus.  This study aimed to identify 254 
bacterial factors that promote adherence of AD strains of S. aureus to corneocytes from AD 255 
skin.  To facilitate this, strains of S. aureus were collected from infected skin lesions of 256 
children with AD (AD strains).  The paediatric patients were presenting for the first time at a 257 
tertiary referral centre in Dublin, Ireland and were treatment naïve (Table S1).  Molecular 258 
typing methods were used to assign each strain to a clonal complex so that the general 259 
population structure of the AD strains could be examined.  The most common clonal complex 260 
(CC) in the AD cohort was CC1 (9 isolates, 20.45%) followed by CC45 (7 isolates, 15.9%), 261 
CC8 (6 isolates, 13.63%) and CC5 (6 isolates, 13.63%) (Fig. 1A).  Commensal S. aureus 262 
strains from a healthy cohort in Dublin, Ireland (children with no history of AD and 263 
asymptomatic nasal carriage) were also typed to the same level (control strains, Fig. 1B)  264 
Only 4.08% and 2.04% of the control strains belonged to CC1 and CC8, respectively, 265 
showing that although CC1 and CC8 strains are frequently recovered from AD skin lesions 266 
they rarely occur as commensal strains in the nares of healthy children in the community 267 
(Fig. 1).  In contrast, while CC30 was the most prevalent clonal complex among the control 268 
strains (33% of strains) only 6.81% of the AD strains belonged to CC30 showing a 269 
statistically significant underrepresentation of CC30 in the AD cohort.  Thus the strains 270 
causing skin infection in paediatric AD patients are different to the commensal strains 271 
circulating in the community.  There were no associations between the S. aureus clonal 272 
complex and NMF levels in the patient’s stratum corneum or the clinical phenotype (Table 273 
S1).   274 
 275 
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Ligand binding activity of AD strains. 276 
Disease causing strains of S. aureus often have increased ability to adhere to host molecules 277 
or increased toxin production compared to commensal strains (30, 31).  We hypothesised that 278 
adhesion to corneocytes is an important first step in the colonisation and infection of AD 279 
skin.  Therefore we employed a phenotypic screening method to study the activity of the S. 280 
aureus adhesin ClfB, a S. aureus CWA protein that binds to loricrin and cytokeratin 10 (14, 281 
15). We examined the in vitro adherence of AD strains to the ClfB ligand L2v, a loricrin 282 
derived peptide fused to GST (Fig. 2).  The well characterised S. aureus strain SH1000 was 283 
included as a control since adherence of SH1000 to L2v is solely dependent on ClfB (14).  284 
The amount of adherence for each clinical strain was expressed as a percentage of the 285 
adherence value measured for SH1000.  The commensal control strains were also tested.  286 
Each data point in Fig. 2 represents the mean adherence level of a single strain.  All AD 287 
strains adhered to immobilized L2v with a median level of adherence relative to SH1000 of 288 
157% (Fig. 2).   The median level of adherence for the control strains was significantly lower 289 
(111%, p < 0.0001).  These results indicate that all S. aureus strains that infect the skin of AD 290 
patients display ClfB ligand binding activity and that this is higher than the S. aureus nasal 291 
carriage control isolates from healthy individuals.  These data suggested that ClfB could be 292 
an important adhesin for AD skin. In addition AD strains from CC1 (red), the most common 293 
clonal complex in the AD cohort, adhered very strongly to L2v with a median adherence 294 
value of 196% (Fig. 2).  For the CC30 strains (green) adherence values ranged between 0 and 295 
155% for the control strains while for the three CC30 AD strains, adherence values ranged 296 
between 144 and 191%.  Adherence values for the CC8 strains (blue) were highly variable 297 
ranging from 41 – 204%.       298 
 299 
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 300 
Adherence of S. aureus to corneocytes from AD patients ex vivo is ClfB-dependent. 301 
The results described above suggested that ClfB ligand binding activity was a universal 302 
feature of our paediatric AD strains.  In order to investigate if adherence of S. aureus to AD 303 
corneocytes requires ClfB, the clfB gene was deleted in a representative AD strain from CC1 304 
(AD08CC1, Table S1).  Western immunoblotting using anti-ClfB IgG indicated that while the 305 
parent strain AD08 expressed ClfB, bands corresponding to ClfB were not detected for the 306 
ClfB-deficient mutant (AD08CC1∆clfB, Fig. 3A).    Complementation of the clfB mutant with 307 
plasmid pCU1::clfB restored the expression of ClfB (Fig. 3A).  The clfB mutant did not 308 
adhere to L2v while the parent strain adhered in a dose-dependent and saturable manner (Fig. 309 
3B).  Complementation of AD08CC1∆clfB with pCU1::clfB restored the ability of the mutant 310 
to adhere to L2v while AD08CC1∆clfB carrying empty plasmid pCU1 could not adhere (Fig. 311 
3C) showing that the ability of AD08CC1 to adhere strongly to L2v can be attributed to the 312 
activity of ClfB.   313 
AD08CC1 and its isogenic ClfB-deficient mutant were used in single cell atomic force 314 
microscopy (AFM) experiments to determine if ClfB is important for the adherence of S. 315 
aureus to AD skin. Corneocytes were collected by tape-stripping the unaffected skin of two 316 
AD patients with low NMF levels and concurrent S. aureus infection at a different site 317 
(patients 1434 and 1473, Table S1).  Previous work has shown that low levels of NMF are 318 
associated with changes in corneocyte morphology in AD skin compared to normal healthy 319 
skin leading to the appearance of villus-like projections (12).  We generated topographic 320 
images of corneocytes from both patients in buffer, using contact mode imaging with silicon 321 
nitride tips (Fig. S1) and found that the corneocytes from FLG AD patients displayed large 322 
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numbers of villus protrusions, about 200 nm in height, consistent with the morphology 323 
expected at low NMF (12). 324 
To investigate if ClfB is important for the adherence of S. aureus to corneocytes from AD 325 
skin, AD08CC1 and its isogenic ClfB-deficient mutant (AD08CC1∆clfB) were used in single-326 
cell force spectroscopy experiments (32, 33) (Fig. 4). A single S. aureus cell was immobilised 327 
on an AFM cantilever and this was used as a probe to measure the binding forces between S. 328 
aureus adhesins and corneocytes.  The average binding force between S. aureus AD08CC1 and 329 
AD corneocytes was similar for both patients (1186 pN and 1109 pN, Fig. 4A). In both cases 330 
there was a statistically significant reduction in binding force when AD08CC1∆clfB was used 331 
as a probe on the same AD corneocytes (670 pN and 749 pN, Fig. 4C). These data provide 332 
direct evidence that ClfB is involved in mediating attachment of S. aureus to AD 333 
corneocytes.  334 
Multiparametric imaging was then used to localise ligands recognised by S. aureus on the 335 
surface of corneocytes from patients 1434 and 1473 (34, 35).  Multiparametric imaging is a 336 
newly developed AFM technique that enables researchers to simultaneously map the 337 
structure, biophysical properties and molecular interactions of biological samples (19).  AFM 338 
cantilevers were functionalised with a single cell of AD08CC1 or AD08CC1∆clfB.  Force curves 339 
were recorded across the corneocyte surface at high frequency, generating maps of structure 340 
and adhesion. Multiple adhesion events with a mean force of ,~ 600 pN occurred between 341 
AD08CC1 and the corneocyte surface indicating that many ligands for S. aureus are exposed 342 
in the stratum corneum of AD patients (Fig. 5).  In contrast, much fewer adhesion events with 343 
a weaker strength (~200 pN) occurred with AD08CC1∆clfB indicating that in the absence of 344 
ClfB, S. aureus is less well able to adhere to corneocytes (Fig. 5).  Importantly, the number of 345 
ligands supporting S. aureus adherence to the surface of corneocytes was greatly reduced for 346 
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the ClfB mutant.  This demonstrates that ClfB is a major adhesin mediating the interaction of 347 
S. aureus with AD skin.     348 
 349 
Ligand binding by ClfB from AD strains 350 
All AD strains adhered to L2v and the median adherence level was high (Fig. 2B).  351 
ClfB is the only S. aureus factor that binds to L2v (Fig. 3, (14).  Variation in the amino-acid 352 
sequence of the ligand binding domains of ClfB has been reported previously (36).  More 353 
sequence differences in ClfB are likely to occur between clonal complexes of S. aureus than 354 
within a clonal complex (36).  Amino acid sequence variation in ClfB could confer a higher 355 
affinity for the ligand.  We isolated genomic DNA from all AD strains and used PCR to 356 
amplify DNA encoding the ligand binding region of ClfB (N2 and N3 subdomains).  All AD 357 
strains carried the clfB gene (data not shown).  DNA sequencing was carried out on the clfB 358 
amplimer that was generated for all of the CC1, CC8 and CC30 strains.  The deduced amino-359 
acid sequences were aligned.  The ClfB N2N3 subdomains of CC1 strains shared 100% 360 
amino acid identity with each other.  The amino acid sequences of ClfBN2N3 from CC8 361 
strains were 92% identical to the CC1 sequence.  The three CC30 AD strains had identical 362 
ClfBN2N3 sequences that shared 94% identity with CC1 ClfB N2N3.  Molecular modelling 363 
was carried out to allow visualisation of the position of the variant residues on the crystal 364 
structure of ClfB N2N3 (Fig. 6A).  This indicated that the residues that vary between CC1 365 
and CC30 are located well away from the trench between N2 and N3.  Thus they are unlikely 366 
to alter the affinity of ligand binding to the trench by the dock, lock and latch mechanism.  367 
However it is possible that an additional, unknown ligand binding site could be located 368 
outside of the trench region.  For example it has recently been shown for the related protein 369 
ClfA that high-affinity binding of ClfA to its ligand fibrinogen involves both the dock, lock 370 
and latch ligand-binding trench and a second interaction site at the top of the N3 subdomain 371 
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(37).  Thus to investigate if sequence differences outside of the trench region in CC1 and 372 
CC30 ClfB might alter the affinity for L2v, 6x histidine-tagged recombinant ClfB N2N3 373 
proteins (rClfB N2N3) were purified from E. coli.  The affinity of rClfB N2N3 with CC1 or 374 
CC30 sequence for L2v was studied using surface plasmon resonance.  GST-tagged L2v was 375 
captured on the surface of a sensor chip that had been coated with anti-GST IgG and 376 
increasing concentrations of rClfB N2N3 proteins were passed over the surface of the coated 377 
sensor chip.  To calculate the KD the amount of binding at equilibrium was plotted against 378 
each rClfB N2N3 concentration and the KD of the interaction was calculated (Fig. 6). 379 
Previously the affinity of CC8 rClfB N2N3 for L2v was calculated to be 2.21 µM (14).  CC1 380 
rClfB N2N3 had a slightly higher affinity for GST-L2v (1.91 ± 0.17 µM, Fig. 6B) than CC30 381 
rClfB N2N3 (3.26 ± 0.36 µM, Fig. 6C).  The small but statistically significant difference in 382 
affinity of CC1 and CC30 ClfB for L2v (p < 0.001) may partially explain why AD strains 383 
from CC1 adhere more strongly to L2v. 384 
 385 
 386 
 387 
  388 
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Discussion  389 
The skin of AD patients differs in several respects from normal skin and provides an 390 
environment where S. aureus can proliferate.  By mutating the clfB gene we have shown the 391 
importance of ClfB in mediating bacterial adherence to corneocytes taken from AD patients 392 
known to be susceptible to S. aureus.  This study used clinically relevant strains isolated from 393 
AD patients, rather than relying on laboratory strains, thus increasing the clinical relevance of 394 
our findings.  Single cell AFM is an important recent technical advance which has allowed 395 
measurement of the forces involved in binding of single bacterial cells to corneocytes (34). 396 
Here we show that a clfB mutant bound significantly less strongly to corneocytes from two 397 
AD patients with low NMF compared to the wild-type S. aureus parent strain.  This 398 
demonstrates the importance of ClfB-mediated adherence to ligands exposed on the 399 
corneocyte surface.  The cornified envelope proteins loricrin and cytokeratin 10 are ligands 400 
for ClfB and it may be through binding to these proteins that ClfB mediates bacterial 401 
attachment to corneocytes.  Alternatively, given the altered corneocyte morphology and 402 
protein expression profiles in AD skin, where NMF levels are low (12, 38, 39) it is possible 403 
that ClfB is binding to other protein ligands.  Additional S. aureus factors are likely to 404 
contribute to the adhesion of S. aureus to corneocytes and colonisation of AD skin.  We 405 
believe that AFM could be used in future research to gain further insight into the molecular 406 
basis of skin colonisation and infection in AD.    407 
There were differences in the overall population structure of S. aureus strains from AD skin 408 
lesions compared to strains isolated from a control population (commensal strains).  This is 409 
not entirely surprising given that the niche occupied by the bacteria is very different (AD skin 410 
lesion versus nasal cavity).  Nevertheless the control strains provided a useful comparison.  411 
Since ClfB is a major determinant of nasal colonisation (14) it was surprising to find that 412 
ClfB ligand binding activity was lower among commensal control strains compared to AD 413 
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strains.  However nasal colonisation is a multifactorial process involving several 414 
staphylococcal factors (40) and the relative contribution of each factor may differ from strain 415 
to strain.  We hypothesise that efficient colonisation of AD skin is also likely to require 416 
additional factors.  Currently there is no explanation as to why there are few CC30 strains 417 
isolated from skin lesions in AD patients while the proportion of CC1 and CC8 strains is 418 
high.  Other studies have found similar trends in AD strain populations from different 419 
geographic locations (41, 42).  A slightly higher binding affinity was measured for the ClfB 420 
from CC1 compared to CC30.  We hypothesise that this difference could be amplified when 421 
multiple copies of ClfB are present on the surface of S. aureus leading to an increase in 422 
avidity.  In addition it is possible that there are strain-dependent differences in the genetic 423 
regulation of clfB expression which could account for differences in the amount of ClfB on 424 
the surface of different strains.  Genetic diversity between strains within a CC can often be 425 
missed using molecular typing approaches (43).  Whole genome sequencing allows a more 426 
detailed analysis of the relationship between strains.  It is likely that the ability to colonize 427 
and to proliferate on AD skin is due to many factors in addition to the ability to adhere to 428 
corneocytes.  A detailed proteomic analysis or transcriptional profiling of clinical isolates 429 
will give full details of the repertoire of virulence and colonisation factors expressed by 430 
strains infecting AD lesions.   Here we have identified a crucial role for ClfB in promoting 431 
adherence of clinically relevant strains of S. aureus to corneocytes from AD skin.  This 432 
finding advances our understanding of the interaction between S. aureus and the altered 433 
environment of AD skin and may inform targeted therapies to reduce colonisation and 434 
infection in AD patients. 435 
 436 
 437 
  438 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
21 
 
Acknowledgements 439 
OMF, McMcA and ADI are funded by the National Children’s Research Centre, Dublin, 440 
Ireland. AMT and JAG are supported by a Research Award from the British Skin Foundation. 441 
WHIM, PGF and ADI were supported by Wellcome Trust (Programme grant 442 
092530/Z/10/Z). Work at the Université catholique de Louvain was supported by the 443 
European Research Council (ERC) under the European Union’s Horizon 2020 research and 444 
innovation programme (grant agreement No [693630]), the National Fund for Scientific 445 
Research (FNRS), the FNRS-WELBIO (Grant n°WELBIO-CR-2015A-05),  the Université 446 
catholique de Louvain (Fonds Spéciaux de Recherche), the Federal Office for Scientific, 447 
Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the 448 
Research Department of the Communauté française de Belgique (Concerted Research 449 
Action). Y.F.D. and C. F.-D. are respectively Research Director and postdoctoral researcher 450 
of the FNRS.  D.A.R. was supported by grant GM080602 from the National Institutes of 451 
Health. The collection and molecular typing of the carriage isolates was supported by funds 452 
from Temple Street Children’s University Hospital.  We gratefully acknowledge the 453 
participation of our patients and their families, without this the study would not have been 454 
possible. Many thanks to our research nurse Nuala Alyward for her assistance in sample 455 
collection and to Stephanie MacCallum and Linda Campbell for FLG genotyping of our 456 
patient series.       457 
 458 
  459 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
22 
 
References 460 
1. Park HY, Kim CR, Huh IS, Jung MY, Seo EY, Park JH, Lee DY, Yang JM. 461 
2013. Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of 462 
Patients with Atopic Dermatitis. Ann Dermatol 25:410-416. 463 
2. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, 464 
Verbrugh HA, Wertheim HF. 2009. Reclassification of Staphylococcus aureus 465 
nasal carriage types. J Infect Dis 199:1820-1826. 466 
3. Kennedy EA, Connolly J, Hourihane JO, Fallon PG, McLean WH, Murray D, Jo 467 
JH, Segre JA, Kong HH, Irvine AD. 2017. Skin microbiome before development of 468 
atopic dermatitis: Early colonization with commensal staphylococci at 2 months is 469 
associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol 470 
139(1):166-172.   471 
4. Tauber M, Balica S, Hsu CY, Jean-Decoster C, Lauze C, Redoules D, Viode C, 472 
Schmitt AM, Serre G, Simon M, Paul CF. 2016. Staphylococcus aureus density on 473 
lesional and nonlesional skin is strongly associated with disease severity in atopic 474 
dermatitis. J Allergy Clin Immunol 137:1272-1274 e1273. 475 
5. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie 476 
DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, 477 
Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, 478 
Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer 479 
LB, Bisgaard H, Mukhopadhyay S, McLean WH. 2006. Common loss-of-function 480 
variants of the epidermal barrier protein filaggrin are a major predisposing factor for 481 
atopic dermatitis. Nat Genet 38:441-446. 482 
6. Irvine AD, McLean WH, Leung DY. 2011. Filaggrin mutations associated with skin 483 
and allergic diseases. N Engl J Med 365:1315-1327. 484 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
23 
 
7. McAleer MA, Irvine AD. 2013. The multifunctional role of filaggrin in allergic skin 485 
disease. J Allergy Clin Immunol 131:280-291. 486 
8. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, Kong 487 
HH, Amagai M, Nagao K. 2015. Dysbiosis and Staphylococcus aureus Colonization 488 
Drives Inflammation in Atopic Dermatitis. Immunity 42:756-766. 489 
9. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U, Werfel T. 490 
2009. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of 491 
highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 161:300-492 
305. 493 
10. Zollner TM, Wichelhaus TA, Hartung A, Von Mallinckrodt C, Wagner TO, 494 
Brade V, Kaufmann R. 2000. Colonization with superantigen-producing 495 
Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin 496 
Exp Allergy 30:994-1000. 497 
11. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, Hasegawa 498 
M, Villaruz AE, Cheung GY, McGavin MJ, Travers JB, Otto M, Inohara N, 499 
Nunez G. 2013. Staphylococcus delta-toxin induces allergic skin disease by 500 
activating mast cells. Nature 503:397-401. 501 
12. Riethmuller C, McAleer MA, Koppes SA, Abdayem R, Franz J, Haftek M, 502 
Campbell LE, MacCallum SF, McLean WH, Irvine AD, Kezic S. 2015. Filaggrin 503 
breakdown products determine corneocyte conformation in patients with atopic 504 
dermatitis. J Allergy Clin Immunol 136:1573-1580 e1571-1572. 505 
13. Cho SH, Strickland I, Boguniewicz M, Leung DY. 2001. Fibronectin and 506 
fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic 507 
skin. J Allergy Clin Immunol 108:269-274. 508 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
24 
 
14. Mulcahy ME, Geoghegan JA, Monk IR, O'Keeffe KM, Walsh EJ, Foster TJ, 509 
McLoughlin RM. 2012. Nasal colonisation by Staphylococcus aureus depends upon 510 
clumping factor B binding to the squamous epithelial cell envelope protein loricrin. 511 
PLoS Pathog 8:e1003092. 512 
15. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ. 2002. Staphylococcus 513 
aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: 514 
implications for nasal colonization. Cell Microbiol 4:759-770. 515 
16. Miajlovic H, Fallon PG, Irvine AD, Foster TJ. 2010. Effect of filaggrin breakdown 516 
products on growth of and protein expression by Staphylococcus aureus. J Allergy 517 
Clin Immunol 126:1184-1190 e1183. 518 
17. Ganesh VK, Barbu EM, Deivanayagam CC, Le B, Anderson AS, Matsuka YV, 519 
Lin SL, Foster TJ, Narayana SV, Hook M. 2011. Structural and biochemical 520 
characterization of Staphylococcus aureus clumping factor B/ligand interactions. J 521 
Biol Chem 286:25963-25972. 522 
18. Ponnuraj K, Bowden MG, Davis S, Gurusiddappa S, Moore D, Choe D, Xu Y, 523 
Hook M, Narayana SV. 2003. A "dock, lock, and latch" structural model for a 524 
staphylococcal adhesin binding to fibrinogen. Cell 115:217-228. 525 
19. Xiao J, Dufrene YF. 2016. Optical and force nanoscopy in microbiology. Nat 526 
Microbiol 1:16186. 527 
20.  Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, 528 
Bingham EA, Finlay AY, Pembroke AC, Graham-Brown RA, Atherton DA, 529 
Lewis-Jones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, 530 
David TJ.  1994. The U.K. Working Party's Diagnostic Criteria for Atopic 531 
Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br 532 
J Dermatol 131:383-396. 533 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
25 
 
21. Sandilands A, Smith FJ, Irvine AD, McLean WH. 2007. Filaggrin's fuller figure: a 534 
glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127:1282-535 
1284. 536 
22. Robinson DA, Enright MC. 2003. Evolutionary models of the emergence of 537 
methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:3926-538 
3934. 539 
23. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. 2002. sigmaB 540 
modulates virulence determinant expression and stress resistance: characterization of 541 
a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 542 
184:5457-5467.  543 
24. Monk IR, Tree JJ, Howden BP, Stinear TP, Foster TJ. 2015. Complete Bypass of 544 
Restriction Systems for Major Staphylococcus aureus Lineages. MBio 6:e00308-545 
00315. 546 
25. Lofblom J, Kronqvist N, Uhlen M, Stahl S, Wernerus H. 2007. Optimization of 547 
electroporation-mediated transformation: Staphylococcus carnosus as model 548 
organism. J Appl Microbiol 102:736-747. 549 
26.  Augustin J, Rosenstein R, Wieland B, Schneider U, Schnell N, Engelke G, Entian 550 
KD, Gotz F. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-551 
negative mutants of Staphylococcus epidermidis. Eur J Biochem 204:1149-1154. 552 
27. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ. 1998. 553 
Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of 554 
Staphylococcus aureus. Mol Microbiol 30:245-257. 555 
28. Kezic S, O'Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, Caspers P, 556 
Kemperman PM, Puppels GJ, Sandilands A, Chen H, Campbell LE, Kroboth K, 557 
Watson R, Fallon PG, McLean WH, Irvine AD. 2012. Filaggrin loss-of-function 558 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
26 
 
mutations are associated with enhanced expression of IL-1 cytokines in the stratum 559 
corneum of patients with atopic dermatitis and in a murine model of filaggrin 560 
deficiency. J Allergy Clin Immunol 129:1031-1039 e1031. 561 
29. Dapic I, Yau N, Kezic S, Kammeyer A. 2013. Evaluation of a HPLC method for the 562 
determination of natural moisturising factors in the human stratum corneum. 563 
Analytical Letters 46:2133–2144. 564 
30. Laabei M, Massey R. 2016. Using functional genomics to decipher the complexity of 565 
microbial pathogenicity. Curr Genet 62:523-525. 566 
31. Lower SK, Lamlertthon S, Casillas-Ituarte NN, Lins RD, Yongsunthon R, 567 
Taylor ES, DiBartola AC, Edmonson C, McIntyre LM, Reller LB, Que YA, Ros 568 
R, Lower BH, Fowler VG, Jr. 2011. Polymorphisms in fibronectin binding protein 569 
A of Staphylococcus aureus are associated with infection of cardiovascular devices. 570 
Proc Natl Acad Sci U S A 108:18372-18377. 571 
32. Beaussart A, El-Kirat-Chatel S, Herman P, Alsteens D, Mahillon J, Hols P, 572 
Dufrene YF. 2013. Single-cell force spectroscopy of probiotic bacteria. Biophys J 573 
104:1886-1892. 574 
33. Beaussart A, El-Kirat-Chatel S, Sullan RM, Alsteens D, Herman P, Derclaye S, 575 
Dufrene YF. 2014. Quantifying the forces guiding microbial cell adhesion using 576 
single-cell force spectroscopy. Nat Protoc 9:1049-1055. 577 
34. Formosa-Dague C, Fu ZH, Feuillie C, Foster TJ, Geoghegan JA, Dufrene YF. 578 
2016. Forces between Staphylococcus aureus and human skin. Nanoscale Horizons 579 
1:298-303. 580 
35. Formosa-Dague C, Speziale P, Foster TJ, Geoghegan JA, Dufrene YF. 2016. 581 
Zinc-dependent mechanical properties of Staphylococcus aureus biofilm-forming 582 
surface protein SasG. Proc Natl Acad Sci U S A 113:410-415. 583 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
27 
 
36. Murphy E, Lin SL, Nunez L, Andrew L, Fink PS, Dilts DA, Hoiseth SK, Jansen 584 
KU, Anderson AS. 2011. Challenges for the evaluation of Staphylococcus aureus 585 
protein based vaccines: monitoring antigenic diversity. Hum Vaccin 7 Suppl:51-59. 586 
37. Ganesh VK, Liang X, Geoghegan JA, Cohen AL, Venugopalan N, Foster TJ, 587 
Hook M. 2016. Lessons from the Crystal Structure of the S. aureus Surface Protein 588 
Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal 589 
Antibody. EBioMedicine doi:10.1016/j.ebiom.2016.09.027. 590 
38. Kezic S, O'Regan GM, Yau N, Sandilands A, Chen H, Campbell LE, Kroboth K, 591 
Watson R, Rowland M, McLean WH, Irvine AD. 2011. Levels of filaggrin 592 
degradation products are influenced by both filaggrin genotype and atopic dermatitis 593 
severity. Allergy 66:934-940. 594 
39. Pellerin L, Henry J, Hsu CY, Balica S, Jean-Decoster C, Mechin MC, Hansmann 595 
B, Rodriguez E, Weindinger S, Schmitt AM, Serre G, Paul C, Simon M. 2013. 596 
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J 597 
Allergy Clin Immunol 131:1094-1102. 598 
40. Weidenmaier C, Goerke C, Wolz C. 2012. Staphylococcus aureus determinants for 599 
nasal colonization. Trends Microbiol 20:243-250.  600 
41. Rojo A, Aguinaga A, Monecke S, Yuste JR, Gastaminza G, Espana A. 2014. 601 
Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than 602 
superantigens be involved? Eur J Clin Microbiol Infect Dis 33:651-658. 603 
42. Yeung M, Balma-Mena A, Shear N, Simor A, Pope E, Walsh S, McGavin MJ. 604 
2011. Identification of major clonal complexes and toxin producing strains among 605 
Staphylococcus aureus associated with atopic dermatitis. Microbes Infect 13:189-197. 606 
43.  Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, Ogilvy-Stuart 607 
AL, Ellington MJ, Quail MA, Bentley SD, Parkhill J, Peacock SJ. 2013. Whole-608 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
28 
 
genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus 609 
aureus: a descriptive study. Lancet Infect Dis 13:130-136. 610 
 611 
 612 
 613 
 614 
 615 
 616 
 617 
 618 
 619 
 620 
  621 
 o
n
 April 14, 2017 by Univ of Dundee
http://iai.asm
.org/
D
ow
nloaded from
 
29 
 
Figure Legends 622 
Fig. 1. Clonal complex assignments of AD strains and control strains of S. aureus.  623 
Swabs were taken from a clinically infected site on the AD patient’s skin (A, AD strains) or 624 
from the anterior nares of asymptomatic carriers (B, control strains).  A single colony isolate 625 
from each patient was spa typed.  One or more isolates of each unique spa type were 626 
subjected to multilocus sequence typing and clonal complex (CC) was assigned by eBURST 627 
analysis. 628 
 629 
Fig. 2.  Adherence of S. aureus strains to L2v.  Control strains (■) or AD strains (●) were 630 
grown to exponential phase, adjusted to an OD600 = 1.0 and incubated in wells coated with 631 
L2v at 37°C.  Following incubation wells were washed, adherent bacteria were stained with 632 
crystal violet and the absorbance was read at 570 nm.  Each data point represents the mean 633 
adherence value of a single strain from three independent experiments expressed as a 634 
percentage of the absorbance value measured for strain SH1000.  Strains from CC1 are 635 
shown in red, CC8 in blue, CC30 in green and other CCs in black.  The horizontal lines 636 
represent the median adherence value for the population. Statistical analysis was performed 637 
using an unpaired t-test, *** p< 0.001. 638 
 639 
Fig.  3. Characterisation of a ClfB-deficient mutant of S. aureus AD08CC1.  A) The S. 640 
aureus strain AD08CC1 (1), its isogenic ClfB-deficient mutant AD08CC1∆clfB (2) and 641 
complemented mutant AD08CC1∆clfB (pCU1::clfB) (3) were grown to exponential phase.  642 
Cell wall extracts were separated on 7.5 % acrylamide gels, blotted onto PVDF membranes 643 
and ClfB was detected using polyclonal rabbit antibodies.  Bound antibody was detected 644 
using horseradish peroxidise-conjugated protein A.  Size markers (kDa) are indicated.   645 
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B)  S. aureus strain AD08CC1 (●) and AD08CC1∆clfB (■) were grown to exponential phase, 646 
washed and incubated in microtiter plates coated with L2v.  Adherent cells were stained with 647 
crystal violet and the absorbance was read at 570 nm.  The graph shown is representative of 648 
three independent experiments. 649 
C) S. aureus strain AD08CC1 (red) or mutants AD08CC1∆clfB (blue), AD08CC1∆clfB (pCU1) 650 
(white) and AD08CC1∆clfB (pCU1::clfB) (green) were grown to exponential phase, washed 651 
and incubated in microtiter plates coated with L2v (0.625 μg/ml).  Adherent cells were 652 
stained with crystal violet and the absorbance was read at 570 nm.  Error bars represent the 653 
standard error of the mean values obtained from three independent experiments. Statistical 654 
significance was determined with Student's unpaired t-test, **P  = 0.0059, ***P < 0.0001.  655 
 656 
Fig. 4.  Strength of the S. aureus-corneocyte interaction. (a) Box-chart of the adhesion 657 
forces recorded between S. aureus AD08CC1 or S. aureus AD08CC1∆clfB and corneocytes 658 
from patient 1434. (b) Representative force curves recorded in each condition. (c) Box-chart 659 
of the adhesion force between S. aureus AD08CC1 or S. aureus AD08CC1∆clfB and 660 
corneocytes from patient 1473. (d) Representative force curves recorded in each condition. 661 
All curves were obtained using an applied force of 250 pN and an approach and retraction 662 
speed of 1.0 µm/s. In each case, values calculated from force curves recorded for 5 different 663 
S. aureus-corneocyte pairs were pooled and represented as box-charts, showing mean 664 
adhesion (full circle), median, first and third quartiles (box), range of data without outliers 665 
(whiskers), 99th percentile (open circle) and extreme outliers (triangles).   Statistical analysis 666 
was performed using an unpaired t-test, *** p < 0.0001.  667 
 668 
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Fig. 5. Nanoscale multiparametric imaging of corneocytes using single S. aureus probes. 669 
(a) Height image of a corneocyte coming from patient 1434 recorded in PBS using a S. 670 
aureus AD08CC1 cell probe, and (b) corresponding adhesion image. (c) Height image of a 671 
corneocyte coming from patient 1434 recorded in PBS using a S. aureus AD08CC1∆clfB cell 672 
probe, and (d) corresponding adhesion image.  For both conditions, similar data were 673 
obtained in two other independent experiments. 674 
 675 
Fig. 6. Binding of rClfB N2N3 to L2v.  A) Ribbon representation of the crystal structure of 676 
the N2N3 subdomains of ClfB showing the residues that vary between the CC1 and CC30 677 
sequences (red).  The ClfB ligand bound in the trench between subdomains N2 and N3 is 678 
shown in stick format (blue).  Representative sensorgrams showing binding of rClfB N2N3 to 679 
L2v in a single cycle kinetics assay. GST-tagged L2v was captured on a CM5 chip coated 680 
with anti-GST IgG and increasing concentrations of rClfB N2N3 with the CC1 (B) or CC30 681 
(C) sequence were passed over the surface. Binding was plotted as response units against 682 
time. The affinities were calculated from curve fitting to a plot of the response unit values 683 
against concentrations of rClfB N2N3.  The data shown is representative of 3 individual 684 
experiments. 685 
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